WHO has made available the membership of the Guidelines Development Group (GDG) for the update of the WHO "Consolidated Guidelines for use of antiretrovirals for preventing and treating HIV infection."
Roles: Everyone: All Users
The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.
One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T
Regions: Canada , France , Italy , United Kingdom
Topics: Global Health
On World Hepatitis Day 2020, WHO is calling for united and stepped-up action to prevent mother-to-child transmission of hepatitis B (HBV), a preventable viral infection that attacks the liver and claims the lives of nearly 900 000 people each year.
Topics: Coronavirus (COVID-19), Global Health
The European Medicines Agency announced today that its human medicines committee provided a positive benefit-risk opinion on the use of the Dapivirine Vaginal Ring (DPV-VR) for HIV prevention. WHO stresses that when providing HIV prevention for women it is always critical to provide these alongside other services including STI diagnosis and treatment, HIV testing and links to antiretroviral therapy for all women who test positive and a range of contraception options.
Regions: Kenya
Topics: Global Health, Global Women's Issues